AAPG (AAPG) Earnings Call Analysis

9/25

Growth 3 Margin 1 Expansion 3 Platform 0 Financial 2

latest quarter score

Earnings Reports

9
Ascentage Pharma (AAPG) Q2 2026: 29% Revenue Growth Accelerates Global Hematology Expansion
August 20, 2026
11
AAPG Q4 2025: Dual Product Launch Drives 90% Revenue Surge, Global Trial Enrollment Sets 2027 NDA Path
March 26, 2026
14
AAPG Q1 2025: Dual-Engine Commercialization Drives 90% Revenue Growth, Global Trial Enrollment Accelerates
March 26, 2026
17
AAPG Q2 2025: Olverembatinib China Sales Surge 93% as Dual-Engine Strategy Accelerates Hematology Expansion
August 21, 2025

Browse all companies